|

aglatimagene besadenovec + valacyclovir Clinical Trials

1 actively recruiting trial across 1 location

Also known as: CAN-2409 plus prodrug

Pipeline

Phase 2: 1

Top Sponsors

  • Candel Therapeutics, Inc.1

Indications

  • Prostate Cancer Patients Treated by Radiotherapy1
  • Prostate Cancer (Adenocarcinoma)1
  • Cancer1

Peoria, Arizona1 trial

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

Academic Urology and Urogynecology of Arizona

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.